In the first quarter of 2019, Latvia's Olainfarm will deliver second-line anti-tubercular drugs worth $1 million to the World Health Organization.
In particular, Olainfarm is to provide Aminosalicylic Acid, used by the WHO to treat tuberculosis in developing countries in Asia and Africa.
Olainfarm has been producing the drug since 2001. Inter alia, it delivers Aminosalicylic Acid to clinics in the Baltics and to the international NGO, Médecins Sans Frontières, the company told the press.
Seen a mistake?
Select text and press Ctrl+Enter to send a suggested correction to the editor
Select text and press Report a mistake to send a suggested correction to the editor